Emo Capital Corp

PINK:NUVI USA Shell Companies
Market Cap
$8.51 Million
Market Cap Rank
#31655 Global
#10416 in USA
Share Price
$0.02
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.02
All Time High
$0.04
About

Emo Capital Corp. operates as a carbon farming company. It is involved in the carbon sequestration business, including carbon sink farms/ranches activities; and development and sale of organic fertilizers, biochar, and carbon credit transactions. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Emo Capital Corp (NUVI) - Net Assets

Latest net assets as of July 2015: $-60.41K USD

Based on the latest financial reports, Emo Capital Corp (NUVI) has net assets worth $-60.41K USD as of July 2015.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($60.41K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-60.41K
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 1145.61

Emo Capital Corp - Net Assets Trend (2007–2015)

This chart illustrates how Emo Capital Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Emo Capital Corp (2007–2015)

The table below shows the annual net assets of Emo Capital Corp from 2007 to 2015.

Year Net Assets Change
2015-07-31 $-60.41K -224.69%
2014-07-31 $48.45K +243.14%
2013-07-31 $-33.85K -19.63%
2012-07-31 $-28.30K -83.22%
2010-07-31 $-15.44K -31.72%
2009-07-31 $-11.72K -671.67%
2008-07-31 $2.05K +1951.00%
2007-07-31 $100.00 --

Equity Component Analysis

This analysis shows how different components contribute to Emo Capital Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 98715000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (July 2025)

Component Amount Percentage
Common Stock $420.50K %
Other Components $507.50K %
Total Equity $-61.05K 100.00%

Emo Capital Corp Competitors by Market Cap

The table below lists competitors of Emo Capital Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Emo Capital Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -68,178 to -61,050, a change of 7,128.
  • Net loss of 623 reduced equity.
  • Other factors increased equity by 7,751.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-623.00 -1.02%
Other Changes $7.75K +12.7%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Emo Capital Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-07-31 $0.00 $0.02 x
2008-07-31 $0.00 $0.02 x
2009-07-31 $0.00 $0.02 x
2010-07-31 $0.00 $0.02 x
2011-07-31 $0.00 $0.02 x
2012-07-31 $0.00 $0.02 x
2013-07-31 $0.00 $0.02 x
2014-07-31 $0.00 $0.02 x
2015-07-31 $0.00 $0.02 x
2019-07-31 $0.00 $0.02 x
2020-07-31 $0.00 $0.02 x
2021-07-31 $0.00 $0.02 x
2022-07-31 $0.00 $0.02 x
2023-07-31 $0.00 $0.02 x
2024-07-31 $0.00 $0.02 x
2025-07-31 $-0.14 $0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Emo Capital Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-217.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 -1900.00% 0.00% 0.00x 15.05x $-1.91K
2008 -1367.58% 0.00% 0.00x 3.72x $-28.25K
2009 0.00% 0.00% 0.00x 0.00x $-12.60K
2010 0.00% 0.00% 0.00x 0.00x $-2.17K
2011 0.00% 0.00% 0.00x 0.00x $-1.88K
2012 0.00% 0.00% 0.00x 0.00x $-6.22K
2013 0.00% 0.00% 0.00x 0.00x $-2.17K
2014 0.00% 0.00% 0.00x 0.00x $1.43K
2015 0.00% 0.00% 0.00x 0.00x $-2.83K
2019 0.00% 0.00% 0.00x 0.00x $-653.96K
2021 0.00% 0.00% 0.00x 0.00x $5.54K
2022 0.00% 0.00% 0.00x 0.00x $4.89K
2023 0.00% 0.00% 0.00x 0.00x $-1.10 Million
2024 0.00% 0.00% 0.00x 0.00x $-591.08K
2025 0.00% 0.00% 0.00x 0.00x $5.48K

Industry Comparison

This section compares Emo Capital Corp's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Emo Capital Corp (NUVI) $-60.41K -1900.00% N/A $4.50 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K